The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Self-citationApolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801
Self-citationABC Transporters and the Blood-Brain Barrier
Begley, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384844 · Cited by 545
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
Self-citationKreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469
Self-citationLong-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443
Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438
Self-citationChemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, S. E., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434
Self-citationInfluence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain
Kreuter, J. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2003.077 · Cited by 362
Self-citationAlyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352
Self-citationMichaelis, K., Hoffmann, M. M., Dreis, S., Herbert, E., Alyautdin, R. N., Michaelis, M., Kreuter, J., & Langer, K. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097139 · Cited by 303
Self-citationGöppert, T. M., & Müller, R. H. (2005) · Journal of Drug Targeting · doi:10.1080/10611860500071292 · Cited by 299
Petri, B., Bootz, A., Khalansky, A., Hekmatara, T., Müller, R., Uhl, R., Kreuter, J., & Gelperina, S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.015 · Cited by 298
Self-citationTosi, G., Costantino, L., Rivasi, F., Ruozi, B., Leo, E., Vergoni, A. V., Tacchi, R., Bertolini, A., Vandelli, M. A., & Forni, F. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.022 · Cited by 234
Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier
Costantino, L., Gandolfi, F., Tosi, G., Rivasi, F., Vandelli, M. A., & Forni, F. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.013 · Cited by 208
Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery
Vauthier, C., Labarre, D., & Ponchel, G. (2007) · Journal of drug targeting · doi:10.1080/10611860701603372 · Cited by 126
Ambruosi, A., Gelperina, S. E., Khalansky, A. S., Tanski, S., Theisen, A., & Kreuter, J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600788080 · Cited by 106
Self-citationПереверзева, Э. Р., Трещалин, И. Д., Бодягин, Д. А., Максименко, О. О., Langer, K., Dreis, S., Asmussen, B., Kreuter, J., & Gelperina, S. E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.031 · Cited by 77
Self-citationHekmatara, T., Bernreuther, C., Khalansky, A. S., Theisen, A., Weissenberger, J., Matschke, J., Gelperina, S. E., Kreuter, J., & Glatzel, M. (2009) · Clinical Neuropathology · doi:10.5414/npp28153 · Cited by 61
Self-citationIntravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats
Переверзева, Э. Р., Трещалин, И. Д., Бодягин, Д. А., Максименко, О. О., Kreuter, J., & Gelperina, S. E. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.01.020 · Cited by 47
Self-citationDetermination of loperamide in rat plasma and bovine serum albumin by LC
Chen, H., Gaul, F. E., Gou, D., & Maycock, A. L. (2000) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(99)00312-x · Cited by 24
Encapsulation of Water-Insoluble Drugs in Poly(butyl cyanoacrylate) Nanoparticles
Hekmatara, T., Gelperina, S. E., Vogel, V., Yang, S.-R., & Kreuter, J. (2009) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2009.gr05 · Cited by 18
Self-citationBrioschi, A., Calderoni, S., Pradotto, L., Guido, M., Strada, A., Zenga, F., Benech, C. A., Benech, F., Serpe, L., Zara, G. P., et al. (2009) · Journal of Nanoneuroscience · doi:10.1166/jns.2009.007 · Cited by 11
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Transport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715
Self-citationOvercoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606
Metadata
- Authors
- Gelperina, S., Maksimenko, O., Khalansky, A., Vanchugova, L., Shipulo, E., Abbasova, K., Berdiev, R., Wohlfart, S., Chepurnova, N., & Kreuter, J.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 74
- Issue
- 2
- Pages
- 157-163
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2046480913
- Cited by
- 293
- References
- 23
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.